About Us

Based in South Florida, Organicell™ is a publicly traded biotechnology company committed to the research, development and manufacture of new biologic medicine, with a focus on current and potential regenerative therapeutics. Organicell™ is the leading, fully integrated Exosome Therapeutics Company. Our mission is to transform regenerative medicine by continuing to combine exosome technology with other synergistic therapies and become the healthcare technology incubator for biologic medicine

Executive Leadership

Albert Mitrani
Mari Mitrani, M.D.
George Shapiro, M.D., FACC
Ian T. Bothwell

Executive Leadership

Manuel Iglesias
Albert Mitrani
Mari Mitrani, M.D.
George Shapiro, M.D., FACC
Ian T. Bothwell

Medical Advisory Board

Michale J. Barber, M.D.
Kathy O'Neil-Smith, M.D.
Bryan Kelly, M.D.
Paul Thompson, M.D.
Carolyn DeLucia, M.D.
Paul Francis Campion, M.D.
Sonita Sadio, M.D.
Henry C. Sobo, M.D.
Henry C. Sobo, M.D.
Rolf Wallin, M.D.
Dr. Robert Madda, M.D.
Raymond Ishman, M.D.
William Kapp, M.D., M.S., FAAOS
Stephanie M. Singer, D.O.
Dr. Julian Gershon, D.O.
Rebecca Murray, F.N.P.
Juan Chavez, M.D.
Fernando Pinto, M.D.
Allen J. Meglin, M.D.
Alvaro J. Ocampo, M.D. MPH
David C. Socol, M.D.
John R. Baird, M.D.
Ken Sharlin, M.D.
Randolph Whipps, M.D.
Riley J. Williams III, M.D.
Barry Kuttner, M.D.
Mounir Wassef, DO, FAOCD, FAAD
Robert Neal Rouzier, M. D.
Bennett L. Willard, DO
Dan Sperling, M.D., D.A.B.R.